Volume 111

Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view

J. Kuneš and J. Zicha.........295–305

Signal Transduction Therapy in Haematological Malignancies: Identification and Targeting of Tyrosine Kinases

A. Chase and N. Cross.........233–249

Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential

M. Slevin, P. Kumar, J. Gaffney, S. Kumar, and J. Krupinski.........171–183

Cellular mechanisms underlying the cardiovascular actions of oestrogens

S. Ling, P. Komesaroff and K. Sudhir.........107–118

Therapeutic potential of immunostimulatory monoclonal antibodies

J. C. Gray, P. W. M. Johnson and M. J. Glennie.........93–106

Molecular mechanisms controlling the coupled development of myocardium and coronary vasculature

S Bhattacharya, S MacDonald and C Farthing.........35–46

Eicosanoids and Renal Vascular Function in Diseases

J Imig.........21–34

The Expanding Role of NADPH Oxidases in Health and Disease: No Longer Just Agents of Death and Destruction

M Quinn, M Ammons and F DeLeo.........1–20

Volume 110

Lessons on autoimmune diabetes from animal models

Y. Yang and P. Santamaria.........627–639

Current status of pancreatic islet transplantation

S. Merani and A. M. J. Shapiro.........611–625

Human papillomavirus in cervical screening and vaccination

E. J. Crosbie and H. C. Kitchener.........543–552

Molecular biology of human papillomavirus infection and cervical cancer

J. Doorbar.........525–541

Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host–pathogen interactions in tuberculosis and HIV

J. M. McDermid and A. M. Prentice.........503–524

Searching for genetic clues to the causes of pre-eclampsia

S. Chappell and L. Morgan.........443–458

Antisense therapy in malignant diseases: status quo and quo vadis?

I. Tamm.........427–442

Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity

J. M. R. Gill and D. Malkova.........409–425

Viruses and the brain: from inflammation to dementia

T. Wang, J. A. Rumbaugh and A. Nath.........393–407

Molecular genetics of human hypertension

M. Gong and N. Hubner.........315–326

Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes

C. Portal-Celhay and G. I. Perez-Perez.........305–314

Granulocyte apoptosis in the pathogenesis and resolution of lung disease

S. M. Bianchi, D. H. Dockrell, S. A. Renshaw, I. Sabroe and M. K. B. Whyte.........293–304

Role of osteoprotegerin (OPG) in cancer

I. Holen and C. M. Shipman.........279–291

Adiponectin: a key adipocytokine in metabolic syndrome

Y. Okamoto, S. Kihara, T. Funahashi, Y. Matsuzawa and P. Libby.........267–278

SARS: clinical presentation, transmission, pathogenesis and treatment options

P. K. S. Chan, J. W. Tang and D. S. C. Hui.........193–204

Clinical relevance of the neurotrophins and their receptors

S. J. Allen and D. Dawbarn.........175–191

Neurotrophin signalling in health and disease

M. V. Chao, R. Rajagopal and F. S. Lee.........167–173

RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights

L. Jin and A. L. Burnett.........153–165

Neuroendocrine and metabolic effects of adipocyte-derived hormones

M. B. Jackson and R. S. Ahima.........143–152

Pharmaceutical, cellular and genetic therapies for Huntington's disease

O. J. Handley, J. J. Naji, S. B. Dunnett and A. E. Rosser.........73–88

Therapeutic vaccination against HIV: current progress and future possibilities

R. L. Puls and S. Emery.........59–71

Short interfering RNA (siRNA): tool or therapeutic?

D. Cejka, D. Losert and V. Wacheck.........47–58

Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors

G. S. Ralph, K. Binley, L.-F. Wong, M. Azzouz and N. D. Mazarakis.........37–46

SLPI and elafin: one glove, many fingers

S. E. Williams, T. I. Brown, A. Roghanian and J.-M. Sallenave.........21–35

Antibody- and Fc-receptor-based therapeutics for malaria

J. Shi, R. S. McIntosh and R. J. Pleass.........11–19

The adipocyte life cycle hypothesis

J. Smith, M. Al-Amri, P. Dorairaj and A. Sniderman.........1–9